We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.89T
1-Year Est. Return 35.08%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
-5.64%
1 Year Est. Return
+35.08%
3 Year Est. Return
+108.59%
5 Year Est. Return
+118.76%
10 Year Est. Return
+561.53%
AUM
$741B
AUM Growth
-$68.4B
Cap. Flow
-$3.25B
Cap. Flow %
-0.44%
Top 10 Hldgs %
15.48%
Holding
8,434
New
238
Increased
3,520
Reduced
3,560
Closed
255

Top Sells

Rank Stock Value
1
MA icon
Mastercard
MA
+$2.61B
2
EPAM icon
EPAM Systems
EPAM
+$1.48B
3
TWLO icon
Twilio
TWLO
+$1.35B
4
AAPL icon
Apple
AAPL
+$1.24B
5
TWTR
Twitter, Inc.
TWTR
+$1.18B

Sector Composition

Rank Sector Weight
1 Technology 18.53%
2 Healthcare 9.76%
3 Financials 9.11%
4 Consumer Discretionary 8.41%
5 Communication Services 6.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INAB icon
7151
IN8bio
INAB
$11.6M
$10K ﹤0.01%
97
+33
+52% +$3.69K
INUV icon
7152
Inuvo
INUV
$14.2M
$10K ﹤0.01%
2,039
+1,326
+186% +$6.13K
LNSR icon
7153
LENSAR
LNSR
$102M
$10K ﹤0.01%
1,509
-39
-3% -$244
LWAY icon
7154
Lifeway Foods
LWAY
$377M
$10K ﹤0.01%
1,439
-1
-0.1% -$6
MNPR icon
7155
Monopar Therapeutics
MNPR
$741M
$10K ﹤0.01%
801
+1
+0.1% +$15
MRKR icon
7156
Marker Therapeutics
MRKR
$18.5M
$10K ﹤0.01%
2,284
-1,096
-32% -$6.26K
PLTM icon
7157
GraniteShares Platinum Shares
PLTM
$186M
$10K ﹤0.01%
1,000
-315
-24% -$3.18K
JF
7158
J and Friends Holdings
JF
$17.8M
$10K ﹤0.01%
3,247
+660
+26% +$1.85K
RBKB icon
7159
Rhinebeck Bancorp
RBKB
$199M
$10K ﹤0.01%
1,049
+49
+5% +$525
SYM icon
7160
Symbotic
SYM
$5.43B
$10K ﹤0.01%
1,000
TEQI icon
7161
T. Rowe Price Equity Income ETF
TEQI
$470M
$10K ﹤0.01%
+274
New +$10K
BACK
7162
DELISTED
IMAC Holdings, Inc. Common Stock
BACK
$10K ﹤0.01%
321
LKCO
7163
DELISTED
Luokung Technology Corp Ordinary Shares
LKCO
$10K ﹤0.01%
79
-793
-91% -$112K
BTCY
7164
DELISTED
Biotricity, Inc. Common Stock
BTCY
$10K ﹤0.01%
748
+65
+10% +$1.13K
MDVL
7165
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$10K ﹤0.01%
221
-3,984
-95% -$239K
CCV.WS
7166
DELISTED
Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCV.WS
$10K ﹤0.01%
17,136
BTWNU
7167
DELISTED
Bridgetown Holdings Limited Units
BTWNU
$10K ﹤0.01%
1,041
AGRX
7168
DELISTED
Agile Therapeutics
AGRX
$10K ﹤0.01%
26
-14
-35% -$8.94K
ISO
7169
DELISTED
IsoPlexis Corporation Common Stock
ISO
$10K ﹤0.01%
3,117
+491
+19% +$2.84K
PDOT
7170
DELISTED
Peridot Acquisition Corp. II
PDOT
$10K ﹤0.01%
1,000
BRMK.WS
7171
DELISTED
Broadmark Realty Capital Inc. Warrants, each exercisable for one fourth (1/4th) share of Common Stock at an exercise price of $2.875 per quarter share
BRMK.WS
$10K ﹤0.01%
110,471
COLIU
7172
DELISTED
Colicity Inc. Units
COLIU
$10K ﹤0.01%
1,000
VELO
7173
DELISTED
Velocity Acquisition Corp. Class A Common Stock
VELO
$10K ﹤0.01%
1,000
ASAQ
7174
DELISTED
Atlantic Avenue Acquisition Corp
ASAQ
$10K ﹤0.01%
998
SPAK
7175
DELISTED
Defiance Next Gen SPAC Derived ETF
SPAK
$10K ﹤0.01%
601
-723
-55% -$13.1K

Similar funds

Morgan Stanley's Q1 2022 Portfolio in Review

As of Q1 2022, Morgan Stanley held 8,434 positions worth $741B, down 8.4% from $810B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Morgan Stanley's Q1 2022 filing shows 238 new, 3,520 increased, 3,560 reduced and 255 closed positions. Its largest new stake was Shell: 4,762,346 shares worth $262M. The largest sale was Mastercard, an estimated $2.61B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Morgan Stanley's largest Q1 2022 buy was Shell: 4,762,346 shares worth $262M.
  • Morgan Stanley added most to iShares 20+ Year Treasury Bond ETF in Q1 2022, an estimated $1.86B increase.
  • Morgan Stanley's biggest Q1 2022 reduction was Mastercard, cutting an estimated $2.61B.
  • Morgan Stanley fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $961M.
  • Morgan Stanley's ten largest holdings make up 15% of its $741B portfolio in Q1 2022.
  • Morgan Stanley opened 238 new positions and closed 255 in Q1 2022.
  • Morgan Stanley's portfolio value fell 8.4% quarter-over-quarter to $741B.

Based on Morgan Stanley's 13F filing for Q1 2022, filed 13 May 2022.